亮氨酸丰富α2-糖蛋白1(LRG1)多克隆抗体
Polyclonal Antibody to Leucine Rich Alpha-2-Glycoprotein 1 (LRG1)
- 编号PAB934Mu02
- 物种Mus musculus (Mouse，小鼠) 相同的名称，不同的物种。
- 来源多抗制备
- 宿主兔
- 效价-
- Ig类型 IgG
- 纯化方式抗原特异性亲和纯化
- 标记物无标记物
- 免疫原 RPB934Mu02-亮氨酸丰富α2-糖蛋白1(LRG1)重组蛋白
- 缓冲液成份磷酸盐缓冲液（pH7.4,含有0.02% NaN3和50%甘油）
- 性状液体
- 浓度500µg/mL
- 且适物种-
- 应用WB; IHC; ICC; IP.
如果抗体需用于流式细胞术，请参见流式抗体。 - 下载 英文说明书 中文说明书
- 规格 20µl100µl 200µl 1ml 10ml
- 价格 ¥ 616 ¥ 1436 ¥ 2052 ¥ 5130 ¥ 20520
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
-
产品包装(模拟)
-
产品包装(模拟)
-
Western Blot; Sample: Lane1: Mouse Lung lysate; Lane2: Sp2/0 cell lysate Primary Ab: 0.2µg/ml Rabbit Anti-Mouse LRG1 Antibody Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
-
通过ISO 9001、ISO 13485质量体系认证
特异性
该抗体是针对LRG1的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别LRG1。
用法
Western blotting: 0.5-2µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
赠品
增值服务
相关产品
| 编号 | 适用物种：Mus musculus (Mouse，小鼠) | 应用(仅供研究使用，不用于临床诊断！) |
| RPB934Mu02 | 亮氨酸丰富α2-糖蛋白1(LRG1)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB934Mu03 | 亮氨酸丰富α2-糖蛋白1(LRG1)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB934Mu01 | 亮氨酸丰富α2-糖蛋白1(LRG1)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB934Mu01 | 亮氨酸丰富α2-糖蛋白1(LRG1)多克隆抗体 | WB; IHC; ICC; IP. |
| PAB934Mu03 | 亮氨酸丰富α2-糖蛋白1(LRG1)多克隆抗体 | WB; IHC; ICC; IP. |
| PAB934Mu02 | 亮氨酸丰富α2-糖蛋白1(LRG1)多克隆抗体 | WB; IHC; ICC; IP. |
| SEB934Mu | 亮氨酸丰富α2-糖蛋白1(LRG1)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB934Mu | 亮氨酸丰富α2-糖蛋白1(LRG1)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| Clin Exp Nephrol | Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome [PubMed: 26351173] |
| Journal of Proteome Research | Targeted proteomics predict a sustained complete-response after transarterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma: a prospective cohort study [pubmed:28112944] |
| OncoTargets and Therapy | leucine-rich alpha-2-glycoprotein-1 is up-regulated in colorectal cancer and is a tumor promoter [Pubmed:29785123] |
| PROTEOMICS – Clinical Applications | Screening and Identification of Pregnancy Zone Protein (PZP) and Leucine‐Rich Alpha‐2‐Glycoprotein (LRG) as Potential Serum Biomarkers for Early‐onset … [Pubmed: 30411527] |
| Cancer Management and Research | iTRAQ-based quantitative protein expression profiling of biomarkers in childhood B-cell and T-cell acute lymphoblastic leukemia [Pubmed: 31440093] |
| J Clin Med | A Three-Protein Panel to Support the Diagnosis of Sepsis in Children [Pubmed:35329889] |
留言咨询